Cargando…
Comparison of CE-FDG-PET/CT with CE-FDG-PET/MR in the evaluation of osseous metastases in breast cancer patients
BACKGROUND: Despite improvements in treatments, metastatic breast cancer remains difficult to cure. Bones constitute the most common site of first-time recurrence, occurring in 40–75% of cases. Therefore, evaluation for possible osseous metastases is crucial. Technetium 99 ((99)Tc) bone scintigraphy...
Autores principales: | Catalano, O A, Nicolai, E, Rosen, B R, Luongo, A, Catalano, M, Iannace, C, Guimaraes, A, Vangel, M G, Mahmood, U, Soricelli, A, Salvatore, M |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4453670/ https://www.ncbi.nlm.nih.gov/pubmed/25871331 http://dx.doi.org/10.1038/bjc.2015.112 |
Ejemplares similares
-
PET/MR in invasive ductal breast cancer: correlation between imaging markers and histological phenotype
por: Catalano, Onofrio Antonio, et al.
Publicado: (2017) -
[(18)F]FDG uptake of the normal spinal cord in PET/MR imaging: comparison with PET/CT imaging
por: Aiello, Marco, et al.
Publicado: (2020) -
Clinical Impact of FDG-PET/CT Compared with CE-CT in Response Monitoring of Metastatic Breast Cancer
por: Naghavi-Behzad, Mohammad, et al.
Publicado: (2021) -
A case series on the role of (18)F-FDG PET/CT-guided biopsy of osseous metastases
por: Farrell, Michael, et al.
Publicado: (2021) -
Cost-effectiveness analysis of MRI, CE-CT and 18F-FDG PET/CT for detecting colorectal liver metastases eligible for hepatic resection
por: Schnitzer, Moritz L., et al.
Publicado: (2023)